SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 78.57 |
| Enterprise Value ($M) | -14.74 |
| Book Value ($M) | 118.77 |
| Book Value / Share | 2.68 |
| Price / Book | 0.66 |
| NCAV ($M) | 118.24 |
| NCAV / Share | 2.66 |
| Price / NCAV | 0.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.26 |
| Return on Assets (ROA) | -0.23 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 33.12 |
| Current Ratio | 33.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 122.11 |
| Assets | 122.63 |
| Liabilities | 3.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -34.42 |
| Net Income | -28.54 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -22.72 |
| Cash from Investing | 91.79 |
| Cash from Financing | 0.93 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Soleus Capital Master Fund, L.P. | 5.10 | ||
| 13D | Biotechnology Value Fund L P | 19.70 | 0.00 | |
| 13G/A | Rtw Investments, Lp | 2.50 | -65.87 | |
| 13G/A | BML Investment Partners, L.P. | 9.40 | 0.00 | |
| 13G/A | PFM Health Sciences, LP | 0.00 | ||
| 13G/A | Soleus Capital, LLC | 5.10 | -47.73 | |
| 13G/A | Bb Biotech Ag | 0.00 | -100.00 | |
| 13D | Tang Capital Management Llc | 9.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 44,461 | 174,619 | 25.46 | |
| 113,334 | 802,365 | 14.12 | |
| 6,593 | 132,605 | 4.97 | |
| 4,494 | 134,896 | 3.33 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ENTO – Entero Therapeutics, Inc. | ENTX – Entera Bio Ltd. |
| ENVB – Enveric Biosciences, Inc. | EQ – Equillium, Inc. |
| ERNA – Ernexa Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io